Inventaire - vos ami⋅e⋅s et communautés sont votre meilleure bibliothèque

Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4+ T Cell Restoration.

auteur·ice

Karen Ingrid Tasca

Camila Renata Corrêa

Mônica Bannwart Mendes

Mariana Gatto

publié dans: Journal of Immunology Research

date de publication: 2018-04-10

langue: anglais

Articles cités 54

Date

Titre

Auteur·ices

2015-06-30

Trends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011

Sheela Shenoi
2014-09-15

Vitamin E concentrations in adults with HIV/AIDS on highly active antiretroviral therapy
2014-09-02

Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study

Maria Prins, Ineke G Stolte, Peter Reiss
2013-12-13

Serious Non-AIDS events: Immunopathogenesis and interventional strategies

Irini Sereti, Jintanat Ananworanich
2013-11-22

HIV protease inhibitors and onset of cardiovascular diseases: a central role for oxidative stress and dysregulation of the ubiquitin-proteasome system

Faadiel Essop
2013-05-23

Loss and dysregulation of Th17 cells during HIV infection

Sandra L Bixler, Joseph J Mattapallil
2013-01-01

Vitamin A and beta-carotene concentrations in adults with HIV/AIDS on highly active antiretroviral therapy.
2012-01-01

Premature and accelerated aging: HIV or HAART?

Richard de Boer, Yelena V Budovskaya, Stanley Brul
2012-12

Immunovirological parameters and cytokines in HIV infection
2012-10-11

Microbial translocation, immune activation, and HIV disease

Nicholas Funderburg, Jason M Brenchley, Nichole R Klatt
2012-09-27

T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis

Antonella d'Arminio Monforte, Gian Vico Melzi D'Eril, Alessandra Barassi, Giulia Marchetti
2012-01-18

The DNA damage response and cancer therapy

Christopher J Lord, Alan Ashworth
2012-05-01

Timing of carcinogenicity studies and predictability of genotoxicity for tumorigenicity in anti-HIV drug development
2011-12-01

Oxidative stress and mitochondrial impairment after treatment with anti-HIV drugs: clinical implications

Nadezda Apostolova
2011-08-11

Prevention of HIV-1 infection with early antiretroviral therapy

Karin Nielsen-Saines, Taha E. Taha, Diane Havlir, Max Essex, Joseph Makhema, Estelle Piwowar-Manning, Beatriz Grinsztejn, Myron S. Cohen, Nagalingeswaran Kumarasamy, Ian Sanne, Susan Eshleman, David Celentano, Kenneth Mayer, Joseph J Eron, Susan Swindells, Mina C Hosseinipour, Johnstone J Kumwenda, Guy de Bruyn, Marybeth McCauley, Theresa Gamble, Jose Henrique Pilotto, Sheela V Godbole, Suwat Chariyalertsak, Joel E Gallant, Heather J Ribaudo, Vanessa Elharrar, James Gita Hakim
2011-04-11

Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy

Antonella d'Arminio Monforte, Camilla Tincati, Giulia Marchetti
2011-01-20

Plasma levels of soluble CD14 independently predict mortality in HIV infection

Netanya G. Sandler, Irini Sereti, Sharon R. Lewin, Sean Emery, Steven G Deeks, Kiat Ruxrungtham, Matthew Law, Martha Nason, Daniel C Douek, Jason M Brenchley, James D Neaton
2011-01-01

High mobility group box protein-1 in HIV-1 infection

Piotr Nowak
2011-04-01

HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy correlates with immune activation and increased levels of LPS

Gabriella d'Ettorre, Giancarlo Ceccarelli, Claudio M. Mastroianni
2011-08-10

Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy

Su Jin Jeong, Young Goo Song, Nam Su Ku, Sang Hoon Han, Jun Yong Choi, June Myung Kim, Sun Bean Kim, Hyun Chul Lee
2010-03-01

Aging and HIV infection: a comparison between older HIV-infected persons and the general population

Pablo Tebas
2010-03

HMGB1 and RAGE in inflammation and cancer,HMGB1 and RAGE in Inflammation and Cancer

Anthony J Coyle
2010-10-01

Serum levels of antioxidant vitamins and mineral elements of human immunodeficiency virus positive subjects in Sokoto, Nigeria
2009-09-08

HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes

Jixin Zhong
2009-10-26

Oxidative imbalance in HIV-1 infected patients treated with antiretroviral therapy
2009-05-01

Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults

Todd M. Hulgan, David W. Haas, Ayumi K Shintani
2009-07-07

Total antioxidant capacity--a novel early bio-chemical marker of oxidative stress in HIV infected individuals
2009-04-13

IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells

Mark Brockman, Sylvie Le Gall, Bruce D. Walker, Florencia Pereyra
2009-04-01

RAGE: a novel biological and genetic marker for vascular disease

Anastasia Z. Kalea, Barry Hudson, Ann Marie Schmidt
2009-01-26

HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity

Steven G Deeks, Andrew N Phillips
2009-12-01

Plasma cytokine levels in Tanzanian HIV-1-infected adults and the effect of antiretroviral treatment

Henrik Ullum, Christian Erikstrup, Martha M Lemnge, Bruno P Mmbando, Lasse S Vestergaard
2009-10-01

Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells

Martyn A. French

Article - wd:Q55512254

Bienvenue sur Inventaire

la bibliothèque de vos ami⋅e⋅s et communautés